Corrections | GenomeWeb



In the 09-20-04 issue of BioInform, a quote in the article, “Bayer Spin-off Teams with Physiomics to Develop ‘Virtual Tumor’ for Drug Dosage Testing,” implied that Entelos does not offer a drug delivery model as part of its services. The company said that it has indeed incorporated drug delivery models into its disease models.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.